A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2004
12/22/2004	EP1487805A1 Pyrimidine derivatives
12/22/2004	EP1487797A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
12/22/2004	EP1487794A1 Monocyclic aroylpyridinones as antiinflammatory agents
12/22/2004	EP1487793A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487774A2 Bipolar trans carotenoid salts and their uses
12/22/2004	EP1487494A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
12/22/2004	EP1487489A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN avb3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
12/22/2004	EP1487480A2 Fusion molecules and methods for treatment of immune diseases
12/22/2004	EP1487472A2 Stabilization of hypoxia inducible factor (hif) alpha
12/22/2004	EP1487456A1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions
12/22/2004	EP1487455A1 Morpholine derivatives substituted at the 2-position by an arylalkylurea group for use as ccr-3 antagonists in the treatment of inflammatory conditions
12/22/2004	EP1487454A1 Morpholine derivatives substituted at the 2-position by a heterocyclylalkylurea group for use as ccr-3 antagonists in the treatment of inflammatory conditions
12/22/2004	EP1487453A1 N- [(2s)-4-(3,4-difluorobenzyl)morpholin-2-yl]methyl -2- 3-[(methylsulphonyl)amino]phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions
12/22/2004	EP1487447A1 Use of proton pump inhibitors for the treatment of airway disorders
12/22/2004	EP1487441A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
12/22/2004	EP1487435A1 Azetidine derivatives as ccr-3 receptor antagonists
12/22/2004	EP1487425A2 Use of a vanilloid as an anti-snoring element
12/22/2004	EP1487424A2 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases
12/22/2004	EP1487423A1 Novel formulation
12/22/2004	EP1487417A2 Dry powder medicament formulations
12/22/2004	EP1487411A2 Inhalable sustained therapeutic formulations
12/22/2004	EP1487273A1 Compositions and methods for treatment of microbial infections
12/22/2004	EP1487272A1 Choline-silicic acid complex with osmolytes and divalent trace elements
12/22/2004	EP1406894B1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
12/22/2004	EP1133486B1 Nonsteroidal antiinflammatories
12/22/2004	EP1051172B1 Method for treating copd
12/22/2004	EP0832253B9 Nucleic acid respiratory syncytial virus vaccines
12/22/2004	CN1556811A 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/22/2004	CN1556805A Piperidine derivative as NMDA receptor antagonist
12/22/2004	CN1556703A 1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1 antagonistic activity
12/22/2004	CN1556702A Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/22/2004	CN1556697A Controlled drug delivery systems providing variable release rates
12/22/2004	CN1555889A Cellar air health care therapeutic agent
12/22/2004	CN1555886A Brilliant bingruilin acetate solid lipid nano particle oral preparation and its preparation method
12/22/2004	CN1555869A Preparation technology and use of Chinese herbal medicine phoenix-tail fern
12/22/2004	CN1555851A Composition possessing lung clearing function and its preparation metod
12/22/2004	CN1555840A Chinese medicinal preparation for treating pharyngolaryngitis and its manufacturing method
12/22/2004	CN1555832A Pepper mint eucalyptus lozenge and its preparation method
12/22/2004	CN1555793A Naringin and its salt used for preparing cough suppressing phlegm tramsforming medicine
12/22/2004	CN1181088C Dinucleotide for treating pulmonary tuberulosis
12/22/2004	CN1181070C Urea substituted imidazoquinolines
12/22/2004	CN1181064C Process for preparing crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
12/22/2004	CN1181048C Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha
12/22/2004	CN1180829C Throat-moistening wild tea and producing process thereof
12/22/2004	CN1180780C Picroside-II as one new medicine for preventing and treating allergic and inflammatory diseases
12/22/2004	CN1180771C Oral cavity adhesive plaster composition for curing gingival disease, laryngopharyngitis and halitosis
12/21/2004	US6833444 An erythromycin-type antibiotic based on a perhydro-oxazolo(5,4-c)oxacyclotetradecine ring; bactericides; antiprotazoa agents; non-polyene and ansa macrolide antibiotics
12/21/2004	US6833436 Short peptides which selectively modulate the activity of serine/threonine kinases
12/21/2004	US6833389 Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful in the treatment of Chlamydia pneumoniae infections
12/21/2004	US6833379 As diuretic agent
12/21/2004	US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004	US6833130 Recombinant microorganisms expressing an oligosaccharide receptor mimic
12/16/2004	WO2004108729A1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF
12/16/2004	WO2004108724A1 Tricyclic compound
12/16/2004	WO2004108717A1 Sulptionamide compounds that modulate chemokine receptor activity (ccr4)
12/16/2004	WO2004108716A1 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents
12/16/2004	WO2004108713A1 Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents
12/16/2004	WO2004108708A1 3-substituted indoles and derivatives thereof as therapeutic agents
12/16/2004	WO2004108692A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
12/16/2004	WO2004108690A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
12/16/2004	WO2004108676A1 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists
12/16/2004	WO2004108675A1 2-amino-pyridine derivatives as beta-2 adrenoreceptor agonists
12/16/2004	WO2004108216A1 The pharmaceutical use of total glucide of peony
12/16/2004	WO2004108163A1 Method for preparing powder exhibiting low susceptibility to electrification
12/16/2004	WO2004108154A1 Prevention of pulmonary immunopathology using mutant bacterial toxins
12/16/2004	WO2004108151A1 Inhibition of sars coronavirus infection with clinically approved antiviral drugs
12/16/2004	WO2004108133A2 Modulators of vr1 receptor
12/16/2004	WO2004108132A1 Staurosporine derivatives for hypereosinophilic syndrome
12/16/2004	WO2003105908B1 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
12/16/2004	US20040254378 2-Methanesulfone group; Side effect reduction; Nonsteroidal Antiinflammatory
12/16/2004	US20040254376 Cyclic amidine derivative
12/16/2004	US20040254375 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor
12/16/2004	US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders
12/16/2004	US20040254249 Nonsteroidal antiinflammatory agents
12/16/2004	US20040254240 Anti-cancer nitro- and thia-fatty acids
12/16/2004	US20040254233 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
12/16/2004	US20040254222 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
12/16/2004	US20040254219 Muscarinic receptors; chronic obstructive pulmonary disease; asthma
12/16/2004	US20040254216 Inhibitors of p38
12/16/2004	US20040254212 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
12/16/2004	US20040254210 Pharmaceutical compositions comprising colloidal silicon dioxide
12/16/2004	US20040254200 Antiinflammatory agents; controlling interleukins, tumor necrosis factor; antiarthritic agents; immunosuppressants
12/16/2004	US20040254198 Respiratory system disorders; asthma; chronic obstructive pulmonary disease
12/16/2004	US20040254192 2,4,5-trisubstituded thiazolyl derivatives and their antiinflammatory activity
12/16/2004	US20040254189 Jnk inhibitors
12/16/2004	US20040254177 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/16/2004	US20040254157 ethyl 4-[(4-[[2-methyl-phenyl)amino]carbonyl]amino)phenyl]amino]-4-oxo-2-phenyl-butanoyl)amino]benzoate for treatment of inflammatory diseases and conditions mediated by integrins (atherosclerosis, asthma, obstructive pulmonary disease, allergies, diabetes, multiple sclerosis, and autoimmune disorders)
12/16/2004	US20040254149 Antiproliferative agents; antiinflammatory agents; anticancer agents; diagnosis, therapy
12/16/2004	US20040254145 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
12/16/2004	US20040254128 Treatment and prevention of heat shock protein-associated diseases and conditions
12/16/2004	US20040254116 Contactor tissue with transforming growth factor kinase receptors; modulate cell proliferation
12/16/2004	US20040254096 Mucin synthesis inhibitors
12/16/2004	US20040253709 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
12/16/2004	US20040253599 Novel protein, its dna and use thereof
12/16/2004	US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders
12/16/2004	US20040253328 Anti-atypical pneumonia decoction
12/16/2004	US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization
12/16/2004	US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease
12/16/2004	US20040253205 c-Kit kinase inhibitor
12/16/2004	CA2528497A1 Tricyclic compound

1 ... 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 ... 878